These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 27838018)

  • 1. Predictive value of premorbid IQ, negative symptoms, and age for cognitive and social functions in Japanese patients with schizophrenia: A study using the Japanese version of the Brief Assessment of Cognition in Schizophrenia.
    Akiyama K; Saito S; Saito A; Ozeki Y; Watanabe T; Fujii K; Honda G; Shimoda K
    Psychiatry Res; 2016 Dec; 246():663-671. PubMed ID: 27838018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive deficits among people with schizophrenia and prediabetes or diabetes.
    John AP; Mya T; Haywood D
    Acta Psychiatr Scand; 2024 Jan; 149(1):65-76. PubMed ID: 37950362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter, randomized controlled trial of individualized occupational therapy for patients with schizophrenia in Japan.
    Shimada T; Ohori M; Inagaki Y; Shimooka Y; Sugimura N; Ishihara I; Yoshida T; Kobayashi M
    PLoS One; 2018; 13(4):e0193869. PubMed ID: 29621261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between social and cognitive functions in people with schizophrenia.
    Tominaga T; Tomotake M; Takeda T; Ueoka Y; Tanaka T; Watanabe SY; Kameoka N; Nakataki M; Numata S; Izaki Y; Sumitani S; Kubo H; Kaneda Y; Ohmori T
    Neuropsychiatr Dis Treat; 2018; 14():2215-2224. PubMed ID: 30214211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Associations between components of metabolic syndrome and cognitive impairment in patients with schizophrenia].
    Kornetova EG; Galkin SA; Mednova IA; Tsiguntsev VV; Boiko AS; Kornetov AN; Ivanova SA; Bokhan NA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(3):82-87. PubMed ID: 38529867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity and applicability of the Brazilian version of the Brief Assessment of Cognition in Schizophrenia (BACS).
    Salgado JV; Carvalhaes CFR; Pires AM; Neves MCLD; Cruz BF; Cardoso CS; Lauar H; Teixeira AL; Keefe RSE
    Dement Neuropsychol; 2007; 1(3):260-265. PubMed ID: 29213399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of individualized occupational therapy on cognition among patients with schizophrenia: A randomized controlled trial.
    Shimada T; Morimoto T; Nagayama H; Nakamura N; Aisu K; Kito A; Kojima R; Yamanushi A; Kawano K; Hikita N; Yotsumoto K; Ebisu T; Kawamura M; Inoue T; Orui J; Asakura T; Akazawa M; Kobayashi M
    Schizophr Res; 2024 Jul; 269():18-27. PubMed ID: 38718691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive Subtyping in Schizophrenia: A Latent Profile Analysis.
    Lim K; Smucny J; Barch DM; Lam M; Keefe RSE; Lee J
    Schizophr Bull; 2021 Apr; 47(3):712-721. PubMed ID: 33098300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Social isolation and cognitive function in patients with schizophrenia: A two years follow-up study.
    Yu B; Sun Z; Li S; Chien IC; Ku PW; Chen LJ
    Schizophr Res; 2024 May; 267():150-155. PubMed ID: 38547717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tablet-Based Cognitive and Eye Movement Measures as Accessible Tools for Schizophrenia Assessment: Multisite Usability Study.
    Morita K; Miura K; Toyomaki A; Makinodan M; Ohi K; Hashimoto N; Yasuda Y; Mitsudo T; Higuchi F; Numata S; Yamada A; Aoki Y; Honda H; Mizui R; Honda M; Fujikane D; Matsumoto J; Hasegawa N; Ito S; Akiyama H; Onitsuka T; Satomura Y; Kasai K; Hashimoto R
    JMIR Ment Health; 2024 May; 11():e56668. PubMed ID: 38815257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Divergent thinking as a predictor of life skills in patients with schizophrenia: Evidence from the modified Tinkertoy Test.
    Nakamura Y; Miyamoto R; Koreki A; Anamizu S; Mimura M
    PCN Rep; 2024 Sep; 3(3):e222. PubMed ID: 38961999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decoding schizophrenia: ChatGPT's role in clinical and neuropsychological assessment.
    El Haj M; Raffard S; Besche-Richard C
    Schizophr Res; 2024 May; 267():84-85. PubMed ID: 38522374
    [No Abstract]   [Full Text] [Related]  

  • 13. Preclinical Models to Investigate Mechanisms of Negative Symptoms in Schizophrenia.
    Barnes SA; Der-Avakian A; Young JW
    Schizophr Bull; 2017 Jul; 43(4):706-711. PubMed ID: 28586462
    [No Abstract]   [Full Text] [Related]  

  • 14. A 1.5-Year Longitudinal Study of Social Activity in Patients With Schizophrenia.
    Ohi K; Sumiyoshi C; Fujino H; Yasuda Y; Yamamori H; Fujimoto M; Sumiyoshi T; Hashimoto R
    Front Psychiatry; 2019; 10():567. PubMed ID: 31447715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of Untreated Prodromal Psychosis and Cognitive Impairments.
    Zhang T; Cui H; Wei Y; Tang X; Xu L; Hu Y; Tang Y; Liu H; Wang Z; Chen T; Li C; Wang J
    JAMA Netw Open; 2024 Jan; 7(1):e2353426. PubMed ID: 38277145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of within-individual variability in cognitive performance in schizophrenia in a South African case-control study.
    Wootton O; Dalvie S; MacGinty R; Ngqengelele L; Susser ES; Gur RC; Stein DJ
    Acta Neuropsychiatr; 2023 Jun; ():1-7. PubMed ID: 37340804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Two Factors of Negative Symptoms and Cognition on Social Functioning in Male Patients with Schizophrenia: A Mediator Model.
    Wang Z; Ling Y; Wang Y; Zhu T; Gao J; Tang X; Yu M; Zhou C; Xu Y; Zhang X; Zhang X; Fang X
    Brain Sci; 2023 Jan; 13(2):. PubMed ID: 36831730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Within-individual variability in cognitive performance in schizophrenia: A narrative review of the key literature and proposed research agenda.
    Wootton O; Dalvie S; Susser E; Gur RC; Stein DJ
    Schizophr Res; 2023 Feb; 252():329-334. PubMed ID: 36708623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Retrospective Study on the Relationship Between Cognitive Function and Social Function in Patients With Schizophrenia.
    Shimada T; Kobayashi G; Saeki Y; Mizukoshi C; Chikazawa K; Nokura K; Hasegawa M; Maeda T; Maeda Y; Kawasaki Y
    J Clin Med Res; 2022 Sep; 14(9):348-356. PubMed ID: 36258838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Premorbid intellectual ability in schizophrenia influence family appraisal related to cognitive impairments: a cross-sectional study on cognitive impairment and family assessments.
    Ebina K; Matsui M; Higuchi Y; Suzuki M
    BMC Psychiatry; 2022 Mar; 22(1):227. PubMed ID: 35361170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.